Evidence map›Paper›PMID 34305054›Full record

ReviewAnalytical sciences : the international journal of the Japan Society for Analytical Chemistry2021

Development and Early Identification of Cannabis Chemotypes during the Plant Growth: Current Analytical and Chemometric Approaches.

Cristiano Bolchi, Marco Pallavicini, Eleonora Casagni, Edgardo Vieira de Manincor, Veniero Gambaro, Michele Dei Cas, Gabriella Roda

Abstract readReview
PubMed Publisher
In one paragraph

Review in Analytical sciences : the international journal of the Japan Society for Analytical Chemistry, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Review
  2. Review
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Cristiano BolchiDepartment of Pharmaceutical Sciences, Università degli Studi di Milano, I-20133, Milano, Italy. cristiano.bolchi@unimi.it.
Marco PallaviciniDepartment of Pharmaceutical Sciences, Università degli Studi di Milano, I-20133, Milano, Italy.
Eleonora CasagniDepartment of Pharmaceutical Sciences, Università degli Studi di Milano, I-20133, Milano, Italy.
Edgardo Vieira de ManincorEcocanapa, via Macchi 44, 20124, Milano, Italy.
Veniero GambaroDepartment of Pharmaceutical Sciences, Università degli Studi di Milano, I-20133, Milano, Italy.
Michele Dei CasDepartment of Health Sciences, Università degli Studi di Milano, I-20133, Milano, Italy.
Gabriella RodaDepartment of Pharmaceutical Sciences, Università degli Studi di Milano, I-20133, Milano, Italy. gabriella.roda@unimi.it.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The identification of cannabis chemotypes at an early stage of a plant's growth, which is long before anthesis, has been intensively pursued in order to control the on-target selection of the cultivar type at the beginning of cultivation, so as to avoid economic and legal drawbacks. However, this issue has been systematically addressed by only few and relatively recent studies of analytical chemistry, possibly because result validations require long-term monitoring of the content and ratio of cannabinoids and terpenes in a great number of plant specimens suitably selected and grown. Here, we review the procedures, the chromatographic techniques and the statistics used in topical investigations during the past thirteen years. Through heterogeneous and not easily comparable approaches, they prove the feasibility of chemotypes safe determination within the first month of a plant's life.

Indexed as

CannabinoidsCannabisChemometricsCannabinoidsCannabinoidscannabis sativaCBDchemotypeplant growthterpenesTHC

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.